The humoral immune response to SARS-CoV-2 mounts and is durable in symptomatic haemodialysis patients
Open Access
- 19 February 2021
- journal article
- letter
- Published by Oxford University Press (OUP) in Nephrology Dialysis Transplantation
- Vol. 36 (6), 1132-1134
- https://doi.org/10.1093/ndt/gfab047
Abstract
Vincenzo La Milia, Silvia Tonolo, Francesco Luzzaro, Claudio Bonato, Andrea Cavalli, Barbara Foglieni, Consuelo Debiase, Monica Limardo, Selena Longhi, Chiara RKeywords
This publication has 12 references indexed in Scilit:
- Humoral Immune Response to SARS-CoV-2 in IcelandThe New England Journal of Medicine, 2020
- Detection of antibodies against SARS-CoV-2 in patients with COVID-19Journal of Medical Virology, 2020
- Rapid Decay of Anti-SARS-CoV-2 Antibodies in Persons with Mild Covid-19The New England Journal of Medicine, 2020
- IgG Antibody Response to SARS-CoV-2 Infection and Viral RNA Persistence in Patients on Maintenance HemodialysisAmerican Journal of Kidney Diseases, 2020
- High Prevalence of Asymptomatic COVID-19 Infection in Hemodialysis Patients Detected Using Serologic ScreeningJournal of the American Society of Nephrology, 2020
- Epidemiology of COVID-19 in an Urban Dialysis CenterJournal of the American Society of Nephrology, 2020
- Clinical and immunological assessment of asymptomatic SARS-CoV-2 infectionsNature Medicine, 2020
- Serology assays to manage COVID-19Science, 2020
- COVID-19 Outbreak in a Large Hemodialysis Center in Lombardy, ItalyKidney International Reports, 2020
- Targeting Immunity in End-Stage Renal DiseaseAmerican Journal of Nephrology, 2017